News

Nuclear safety first

By the end of spring, CVŘ, in collaboration with the Czech State Office for Nuclear Safety, DOE and NNSA organized a training course for nuclear evidence and control organs.

Molten salt opens the path to low-emission waste treatment

We are exploring the gasification of waste using molten salts and CO₂. Our research aims to reduce greenhouse gas emissions and process hard-to-recycle waste.

Successful Completion of the ACES Project Focused on the Behaviour of Concrete in Nuclear Environments

The European project ACES – Assessment of Concrete and Civil Engineering Structures, funded by the Horizon 2020 programme of the European Commission, aimed to improve our understanding of how concrete and other civil engineering structures behave under long-term radiation exposure in nuclear environments.

Press Releases

Petr Březina Appointed as New Director

We’re pleased to announce that Petr Březina, an experienced manager with a strong international background, has been appointed as the new Director of our organisation, effective April 1st, 2025.

Press Releases

Take Advantage of Open Access to the CICRR Infrastructure

The CICRR research infrastructure welcomes scientific teams from both the Czech Republic and abroad, offering exceptional capabilities for experimental research in nuclear technologies, materials engineering, physics, and other fields. Through open access, researchers can utilize unique equipment, advanced analytical methods, and expert facilities, enabling the realization of innovative projects with real-world impact.

Press Releases

New Phase of ITER Divertor Testing Begins at HELCZA Facility

Last week, at our experimental facility HELCZA (High Energy Load Czech Assembly) in Plzeň, we started the next phase of testing the thermal resistance and cooling capabilities of the inner protective envelope of the ITER fusion reactor.

Blog

Innovative Approaches in the Fight Against Incurable Tumors

We are part of the international NuCapCure project, which aims to develop an innovative therapy for patients with aggressive brain cancer, Glioblastoma Multiforme. The research focuses on using neutron and proton radiotherapy combined with targeted biosynthesis of therapeutic compounds.